المؤلفون: Ryo Ariyasu, Noriko Yanagitani, Fumiyoshi Ohyanagi, Ken Uchibori, Tsukasa Hasegawa, Makoto Nishio, Keita Kudo, Shingo Nishikawa, Yuichi Tambo, Atsushi Horiike, Satoru Kitazono

المصدر: International Journal of Clinical Oncology. 26:507-514

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Bevacizumab, business.industry, Phases of clinical research, Combination chemotherapy, Hematology, General Medicine, medicine.disease, Chemotherapy regimen, Gastroenterology, 03 medical and health sciences, Regimen, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Internal medicine, medicine, Mucositis, Surgery, business, Adverse effect, Lung cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6d6f784915f0cfcebc80ffafd4cfc39dTest
https://doi.org/10.1007/s10147-020-01822-7Test

المؤلفون: Akihiko Gemma, Ken Uchibori, Takeshi Horai, Takehiro Tozuka, Masahiro Seike, Atsushi Horiike, Noriko Yanagitani, Hiroshi Yoshida, Yoshiaki Amino, Makoto Nishio, Takahiro Yoshizawa, Hiroaki Sakamoto, Shinya Uematsu, Satoru Kitazono, Tsukasa Hasegawa

المصدر: BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Gastroenterology, Immune checkpoint inhibitors, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Non-small cell lung cancer, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Internal medicine, Genetics, medicine, Humans, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, Proportional hazards model, business.industry, Hazard ratio, Cancer, Retrospective cohort study, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, medicine.disease, Survival Analysis, Confidence interval, Nivolumab, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Dissociated responses, Tomography, X-Ray Computed, business, Progressive disease, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c8ac12f5bf9eb83b622738fcd3ddd93Test
https://doi.org/10.1186/s12885-020-6704-zTest

المؤلفون: Satoru Kitazono, Hiroaki Sakamoto, Shinya Uematsu, Tsukasa Hasegawa, Takahiro Yoshizawa, Makoto Nishio, Masahiro Seike, Takehiro Tozuka, Yoshiaki Amino, Hiroshi Yoshida, Noriko Yanagitani, Akihiko Gemma, Ken Uchibori, Ryo Ariyasu

المصدر: Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100249-(2020)

مصطلحات موضوعية: Adult, Male, Vascular Endothelial Growth Factor A, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, VEGF receptors, Cell, Gastroenterology, Chemo-immunotherapy, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Immune system, Non-small cell lung cancer, Anti-PD-1/PD-L1 antibody, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Chemotherapy, Humans, Cutoff, 030212 general & internal medicine, Lung cancer, RC254-282, Aged, Aged, 80 and over, biology, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, VEGF, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, biology.protein, Female, Non small cell, Antibody, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1185a021928c73f8770304c1d2232bdTest
https://doi.org/10.1016/j.ctarc.2020.100249Test

المؤلفون: Yosuke Dotsu, Makoto Nishio, Junji Koyama, Takahiro Yoshizawa, Shingo Nishikawa, Satoru Kitazono, Tomoaki Sonoda, Atsushi Horiike, Ryo Ariyasu, Noriko Yanagitani, Ken Uchibori, Masafumi Saiki

المصدر: Lung cancer (Amsterdam, Netherlands). 133

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Adenosine Deaminase, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Adenocarcinoma of Lung, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Adenosine deaminase, Stable Disease, Programmed cell death 1, Internal medicine, medicine, Biomarkers, Tumor, Humans, Therapy efficacy, Lung cancer, Aged, Neoplasm Staging, Aged, 80 and over, Chemotherapy, biology, business.industry, Middle Aged, medicine.disease, Survival Analysis, 030104 developmental biology, Nivolumab, Oncology, 030220 oncology & carcinogenesis, biology.protein, Female, Immunotherapy, Antibody, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aa098127d66a94351ce5d28dbe5dfe7Test
https://pubmed.ncbi.nlm.nih.gov/31200826Test